Tivorsan Pharmaceuticals, Inc.' Biglycan for Duchenne Muscular Dystrophy Named One of Windhover Information Inc.'s Top 10 “Hot Space” Projects to Watch

Published: Oct 19, 2011

PROVIDENCE, R.I.--(BUSINESS WIRE)--Tivorsan Pharmaceuticals, Inc., a privately held biotechnology company developing a novel protein therapeutic to combat Duchenne Muscular Dystrophy (DMD), has been selected as one of 2011’s Windhover’s Top 10 Most Interesting “Hot Space” Projects to Watch.

Back to news